Investment Opportunity in a Leading Dermato-Oncology
작성자
관리자
작성일자
2025-03-27
조회수
18
Market Leadership: The product dominates the U.S. market (60% of global sales) and is approved in 72+ countries, including the EU. Top-10 countries by sales: USA, Russia, Colombia, Argentina, Brazil, Canada, Germany, Italy, United Kingdom, France. Patent Protection: Coverage extends through 2028 (US/EU). Established Global Presence: Registered in 70+ markets with a robust commercial footprint. The licensor is open to grant an exclusive global license under the existing IP. Interested parties are invited to execute a CDA and agreement with 3rd party to access confidential data, followed by an initial NBO submission.
